Association between Laboratory Findings and Mortality of Hospitalized Patients with Covid-19 in Mashhad, Iran
Authors
Abstract:
Background and Objective: COVID-19 has enforced high burden on health systems universally. To better allocate limited health equipment, we aimed to investigate the prognostic impacts of laboratory parameters. Materials and Methods: All SARS-CoV-2 patients admitted to Imam-Reza University Hospital, Mashhad, Iran, during three COVID19 peak periods in Iran (March to April 2020, July to August, and October to November 2020) were enrolled the study. Demographic and laboratory data were extracted and compared between survivors and non-survivors. Regression analyses and receiver operating characteristic (ROC curve) were used to identify risk factors and assess the ability of laboratory tests in predicting in-hospital mortality. Results: A total of 2156 COVID19 patients were included in the analysis, with a mean age of 60.20 (±18.8) years. Most patients were male (57%). Multiple regression analysis identified older age (OR=1.01), male sex (OR=2.34), lymphopenia (OR=2.12), LDH >500U/L (OR=2.17), hypernatremia (OR=9.7), urea >45mg/dL (OR=3.6), and BS >200mg/dl (OR=1.93) as significant risk factors for in-hospital death. Using ROC curve analysis, D-dimer (>1000ng/ml) as well as CK-Mb (>28U/L) both with sensitivities and specificities of more than 80% and PPV of about 90% were able to identify patients with higher possibility of in-hospital death. Conclusion: Male sex, older age, lymphopenia, hypernatremia, increased Urea, increased LDH, and hyperglycemia may serve as potential risk factors for in-hospital death. D-dimer and CK-MB may be used in identifying patients with high probability of in-hospital death. These tests may be used in clinical decision-making in order to improve outcomes of patients with COVID-19.
similar resources
Relationship between the history of kidney disease, clinical findings, hospitalization duration, and mortality in COVID-19 patients
Introduction: One of the most critical conditions in the world today is coronavirus (COVID-19). The rapid and unexpected incidence of the disease in various communities has been raised many concerns. Although the respiratory and immune systems are the main targets of COVID-19, acute kidney damage and protein excretion in the urine have also been reported. Managing the disease is even more chall...
full textthe past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Association of nailfold capillary changes with disease activity, clinical and laboratory findings in patients with dermatomyositis
Background: The present study aimed to investigate the Nailfold Capillaroscopy (NC) features of the patients with dermatomyositis (DM) and its correlation with their disease activity indices, physical findings, and laboratory results. Methods: The present cross-sectional study was conducted on 27 DM patients above 16 years old who had referred to an(there are 3 clinics not one) outpatient rh...
full textCT Scan Findings in Patients with COVID-19
Background and purpose: Lung involvement is highly important in patients with Coronavirus disease 2019 (COVID-19) and CT scan plays a major role in diagnosis and treatment of patients. This study investigated a large sample size of COVID-19 patients who performed CT scan. Materials and methods: This descriptive cross-sectional study was done using the CT scan findings of all suspected, probabl...
full textAssessment of Clinical and Laboratory Data among the Readmitted COVID-19 and Non COVID-19 Patients in Iran
Background and Objective: Hospital readmissions are common and expensive. Identifying the patients who are at high risk of readmission can decrease readmission. Hence, in the present study, the clinical characteristics, biomarker results, and Computed Tomography (CT) criteria of all the readmitted patients were assessed. Materials and Methods: Data of 98 readmitted patients to the Baqiyatallah...
full textHematology findings in patients with Coronavirus disease 2019 (COVID-19)
In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...
full textMy Resources
Journal title
volume 30 issue 143
pages 8- 8
publication date 2022-10
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023